Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K233399
Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn® technology b...
Sonoma Pharmaceuticals shares are trading lower by 7.8% Wednesday morning. The company announced a 1-for-20 reverse stock split.
Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn® technology b...
Sonoma Pharmaceuticals (NASDAQ:SNOA) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate...
